Pediatric off-patent drugs study (pods) center for lorazepam sedation
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN275200403367C
- Awardee
-
Case Western Reserve University UEI HJMKEF7EJW69
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,433,832
Award facts
- Opportunity
-
- RFPNICHD200311 Solicitation number
- Contract value 46% obligated
-
- $19,574,003.31 Current, with exercised options
- $22,798,639.31 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers
- Pricing
- Cost No Fee
- Place of performance
- Cleveland, OH 44106, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$36,761 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Change Order | $414,455 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $4,408,916 | |
| Funding Only Action | $795,318 | |
| Funding Only Action | $2,980,853 | |
| Original award | $1,871,051 |
Show all 12
About this award
This is a federal contract award to Case Western Reserve University's Office of Research Administration Division, doing business as University Hospitals of Cleveland, by the National Institute of Diabetes and Digestive and Kidney Diseases, a component of the National Institutes of Health.
The contract, awarded on April 1, 2004, is for the "PEDIATRIC OFF-PATENT DRUGS STUDY (PODS) CENTER FOR LORAZEPAM SEDATION" under the Best Pharmaceutical for Children Act (BPCA) program. The contract has a ceiling value of $22,798,639.31 and a final completion date of November 27, 2013. It is a definitive contract with a cost-no-fee pricing type.
The contract does not have a set-aside designation. As the prime contractor, Case Western Reserve University is providing research administration and other services in support of the BPCA program's objective to study off-patent drugs for pediatric applications, specifically related to lorazepam sedation.
Quick answers
Who was awarded contract HHSN275200403367C?
HHSN275200403367C was awarded to Case Western Reserve University by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on April 1, 2004.
How much is contract HHSN275200403367C worth?
The government has obligated $10,433,832 on HHSN275200403367C. Its current value, with exercised options, is $19,574,003. Its potential value, with all options, is $22,798,639.
Was contract HHSN275200403367C competed?
The extent of competition for HHSN275200403367C was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award